Jagsonpal Pharmaceuticals share news, announcements and annual reports
NSE: JAGSNPHARMBSE: 507789Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹230.96.
29 Oct: open ₹219.52, high ₹231.81, low ₹211.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,466 Cr1,360th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 32.23
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 6.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.80%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,49,04126.1% delivered
Jagsonpal Pharmaceuticals has 549 announcements on record, routine notices left out; 5 in the 30 days to 29 Oct 2026, the latest on 28 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Jagsonpal Pharmaceuticals quarterly results
The board met on 28 Oct 2026 to consider financial results
Notice filed 21 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Jagsonpal Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.Jagsonpal Pharmaceuticals financials, year by year
Annual reports18
- Annual report, year to Mar 202627 Aug 2026
- Annual report, year to Mar 202519 Sep 2025
- Annual report, year to Mar 202427 Aug 2024
- Annual report, year to Mar 20239 Aug 2023, a zip file
- Annual report, year to Mar 202223 Aug 2022, a zip file
13 earlier reports
- Annual report, year to Mar 20217 Sep 2021, a zip file
- Annual report, year to Mar 20205 Sep 2020, a zip file
- Annual report, year to Mar 20195 Sep 2019, a zip file
- Annual report, year to Mar 20185 Oct 2018, a zip file
- Annual report, year to Mar 20023 Oct 2018, a zip file
- Annual report, year to Mar 201711 Oct 2017, a zip file
- Annual report, year to Mar 201610 Oct 2016, a zip file
- Annual report, year to Mar 201510 Sep 2015, a zip file
- Annual report, year to Mar 201418 Sep 2014, a zip file
- Annual report, year to Mar 201314 Nov 2013, a zip file
- Annual report, year to Mar 20125 Nov 2013, a zip file
- Annual report, year to Mar 201125 Jun 2012, a zip file
- Annual report, year to Mar 201013 Apr 2011, a zip file
Investor presentations9
- Presentation28 Oct 2026
- Presentation29 Jul 2026
- Presentation27 Apr 2026
- Presentation21 Jan 2026
- Presentation3 Nov 2025
4 earlier presentations
- Investor Presentation26 Jul 2025
- Presentation26 Jul 2025
- Presentation6 May 2025
- Investor Presentation22 Feb 2022
Earnings calls17
- Link of Recording29 Oct 2026
- Transcript4 Aug 2026
- Link of Recording30 Jul 2026
- Transcript4 May 2026
- Link of Recording28 Apr 2026
12 earlier call documents
- Transcript27 Jan 2026
- Link of Recording22 Jan 2026
- Transcript7 Nov 2025
- Link of Recording4 Nov 2025
- Transcript31 Jul 2025
- Link of Recording28 Jul 2025
- Transcript13 May 2025
- Link of Recording7 May 2025
- Transcript29 Jan 2025
- Link of Recording23 Jan 2025
- Transcript29 Oct 2024
- Link of Recording24 Oct 2024
Jagsonpal Pharmaceuticals share news and announcements
Newest first. Page 1 of 11.
Oct 2026
28 Oct · Results
21 Oct · Board meeting
Sep 2026
23 Sep · General Updates
18 Sep · Meeting
Aug 2026
27 Aug · Updates
Jul 2026
29 Jul · Management
29 Jul · General Updates
29 Jul · Corporate action
29 Jul · Results
22 Jul · Analysts
17 Jul · Updates
Jun 2026
29 Jun · General Updates
2 Jun · Closure of Buy Back
May 2026
18 May · Management
18 May · Management
Apr 2026
27 Apr · Corporate action
27 Apr · Updates
27 Apr · General Updates
27 Apr · Results
22 Apr · Analysts
Mar 2026
12 Mar · Board meeting
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 30 Jul 2026Resultsup 2.40%+2.4 pts vs Nifty 500market median −0.7% · five sessions +4.0% (+2.3 pts vs Nifty 500) · volume 145.1× usual · delivery −36.9 pts against usual · The announcement
- 30 Jul 2026Board or managers changedup 2.40%+2.4 pts vs Nifty 500market median 0.0% · five sessions +4.0% (+2.3 pts vs Nifty 500) · volume 145.1× usual · delivery −36.9 pts against usual · The announcement
- 3 Jun 2026Buybackup 0.12%+0.4 pts vs Nifty 500market median 0.0% · five sessions 0.0% (+0.7 pts vs Nifty 500) · volume 0.4× usual · delivery −12.3 pts against usual · The announcement
- 19 May 2026Board or managers changeddown 1.91%−2.2 pts vs Nifty 500market median 0.0% · five sessions +2.3% (+0.2 pts vs Nifty 500) · volume 0.3× usual · delivery −6.3 pts against usual · The announcement
- 28 Apr 2026Resultsup 0.92%+1.2 pts vs Nifty 500market median −0.7% · five sessions +1.7% (+1.7 pts vs Nifty 500) · volume 2.2× usual · delivery −11.5 pts against usual · The announcement
- 22 Jan 2026Resultsup 0.51%−0.2 pts vs Nifty 500market median −0.7% · five sessions −2.0% (−3.4 pts vs Nifty 500) · volume 4.2× usual · delivery −4.1 pts against usual · The announcement
- 4 Nov 2025Resultsdown 4.36%−3.8 pts vs Nifty 500market median −0.7% · five sessions −6.7% (−6.1 pts vs Nifty 500) · volume 2.2× usual · delivery −1.3 pts against usual · The announcement
- 28 Jul 2025Resultsup 11.19%+11.9 pts vs Nifty 500market median −0.7% · five sessions +3.1% (+4.5 pts vs Nifty 500) · volume 25.7× usual · delivery −32.9 pts against usual · The announcement
- 9 Jul 2025Board or managers changedup 0.26%+0.3 pts vs Nifty 500market median 0.0% · five sessions +7.1% (+7.6 pts vs Nifty 500) · volume 0.4× usual · delivery −0.6 pts against usual · The announcement
- 7 May 2025Resultsdown 8.63%−9.2 pts vs Nifty 500market median −0.7% · five sessions −8.9% (−10.7 pts vs Nifty 500) · volume 1.1× usual · delivery −2.3 pts against usual · The announcement
20 earlier announcements
- 7 May 2025Dividenddown 8.63%−9.2 pts vs Nifty 500market median 0.0% · five sessions −8.9% (−10.7 pts vs Nifty 500) · volume 1.1× usual · delivery −2.3 pts against usual · The announcement
- 21 May 2024Dividenddown 2.74%−2.9 pts vs Nifty 500market median 0.0% · five sessions −7.4% (−9.0 pts vs Nifty 500) · volume 1.0× usual · delivery +11.0 pts against usual · The announcement
- 5 Feb 2024Resultsdown 16.60%−16.3 pts vs Nifty 500market median −0.7% · five sessions −14.2% (−14.5 pts vs Nifty 500) · volume 12.9× usual · delivery +7.7 pts against usual · The announcement
- 5 Feb 2024Board or managers changeddown 16.60%−16.3 pts vs Nifty 500market median 0.0% · five sessions −14.2% (−14.5 pts vs Nifty 500) · volume 12.9× usual · delivery +7.7 pts against usual · The announcement
- 3 Nov 2023Resultsdown 0.99%−1.6 pts vs Nifty 500market median −0.7% · five sessions −4.7% (−6.7 pts vs Nifty 500) · volume 5.1× usual · delivery −2.0 pts against usual · The announcement
- 24 May 2023Dividenddown 0.77%−0.6 pts vs Nifty 500market median 0.0% · five sessions +1.4% (−0.2 pts vs Nifty 500) · volume 0.7× usual · delivery −17.7 pts against usual · The announcement
- 23 May 2023Dividenddown 0.40%−0.7 pts vs Nifty 500market median 0.0% · five sessions −0.7% (−2.5 pts vs Nifty 500) · volume 5.7× usual · delivery −37.1 pts against usual · The announcement
- 2 Jan 2023Board or managers changeddown 1.13%−1.6 pts vs Nifty 500market median 0.0% · five sessions 0.0% (+1.1 pts vs Nifty 500) · volume 0.4× usual · delivery +4.5 pts against usual · The announcement
- 2 Feb 2022Board or managers changedup 1.79%+0.6 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−0.9 pts vs Nifty 500) · volume 0.8× usual · delivery −1.6 pts against usual · The announcement
- 20 Oct 2021Dividendup 1.48%+2.7 pts vs Nifty 500market median 0.0% · five sessions +8.8% (+10.4 pts vs Nifty 500) · volume 2.0× usual · delivery −6.4 pts against usual · The announcement
- 1 Jul 2021Dividenddown 3.71%−3.6 pts vs Nifty 500market median 0.0% · five sessions −4.4% (−5.5 pts vs Nifty 500) · volume 0.3× usual · delivery +10.4 pts against usual · The announcement
- 12 Feb 2021Resultsup 1.92%+2.0 pts vs Nifty 500market median −0.7% · five sessions +10.9% (+10.5 pts vs Nifty 500) · volume 1.5× usual · delivery +9.5 pts against usual · The announcement
- 29 Jul 2020Dividenddown 5.00%−4.5 pts vs Nifty 500market median 0.0% · five sessions −3.5% (−2.8 pts vs Nifty 500) · volume 1.4× usual · delivery +12.0 pts against usual · The announcement
- 29 May 2019Dividendup 6.83%+7.4 pts vs Nifty 500market median 0.0% · five sessions +7.0% (+6.4 pts vs Nifty 500) · volume 2.7× usual · delivery +3.9 pts against usual · The announcement
- 31 May 2018Dividenddown 1.31%−2.0 pts vs Nifty 500market median 0.0% · five sessions −7.3% (−6.8 pts vs Nifty 500) · volume 0.6× usual · delivery −15.1 pts against usual · The announcement
- 3 Oct 2017Dividendup 1.96%+1.2 pts vs Nifty 500market median 0.0% · five sessions +4.7% (+2.4 pts vs Nifty 500) · volume 0.3× usual · delivery −8.7 pts against usual · The announcement
- 29 May 2017Dividenddown 4.95%−4.6 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−3.7 pts vs Nifty 500) · volume 0.8× usual · delivery +2.4 pts against usual · The announcement
- 31 May 2016Dividendup 1.65%+1.9 pts vs Nifty 500market median 0.0% · five sessions +21.2% (+21.0 pts vs Nifty 500) · volume 2.2× usual · delivery +10.2 pts against usual · The announcement
- 29 May 2015Dividenddown 0.75%−2.1 pts vs Nifty 500market median 0.0% · five sessions −14.0% (−11.7 pts vs Nifty 500) · volume 3.3× usual · The announcement
- 4 Jun 2012Dividenddown 0.81%−0.8 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−6.2 pts vs Nifty 500) · volume 4.0× usual
Jagsonpal Pharmaceuticals results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Other expenses | Quarter to Jun 2022 | Standalone | 13.77 | 12.61 | −8.4% | 29 Aug 2022 | 22 Nov 2022 |
| Total expenses | Quarter to Jun 2022 | Standalone | 54.39 | 53.63 | −1.4% | 29 Aug 2022 | 22 Nov 2022 |
| Profit before tax | Quarter to Jun 2022 | Standalone | 0.72 | 3.83 | +431.2% | 29 Aug 2022 | 22 Nov 2022 |
| Tax | Quarter to Jun 2022 | Standalone | 0.35 | 0.90 | +157.7% | 29 Aug 2022 | 22 Nov 2022 |
| Net profit | Quarter to Jun 2022 | Standalone | 0.37 | 2.92 | +691.1% | 29 Aug 2022 | 22 Nov 2022 |
| Change in stock held | Quarter to Jun 2022 | Standalone | 1.88 | 2.28 | +21.1% | 29 Aug 2022 | 22 Nov 2022 |
| Profit before one-off items and tax | Quarter to Jun 2022 | Standalone | 6.52 | 7.29 | +11.7% | 29 Aug 2022 | 22 Nov 2022 |
| One-off items | Quarter to Jun 2022 | Standalone | −5.80 | −3.46 | +40.4% | 29 Aug 2022 | 22 Nov 2022 |
| Current tax | Quarter to Jun 2022 | Standalone | 0.82 | 1.78 | +117.9% | 29 Aug 2022 | 22 Nov 2022 |
| Deferred tax | Quarter to Jun 2022 | Standalone | −0.47 | −0.88 | −88.0% | 29 Aug 2022 | 22 Nov 2022 |